https://www.selleckchem.com/products/ars-1620.html
Most studies exhibited a risk of bias. The current body of evidence of costs of illness of SMA is relatively scarce and characterized by considerable variability across geographical settings and disease phenotypes. Our review provides data pertaining to the economic impact of SMA, which is of particular relevance in light of emerging treatments and ongoing research in this field, and underscores the substantial unmet medical need in this patient population. The current body of evidence of costs of illness of SMA is relatively scarce an
Aimer
Commentaire
Partagez
